Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study

This publication has 23 references indexed in Scilit:

• Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
  Clinical Gastroenterology and Hepatology, 2015
• Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease
  Journal of Hepatology, 2014
• Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH
  Hepatology, 2013
• Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network
  Hepatology International, 2011
• Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
  Journal of Hepatology, 2009
• Clinicopathological significance of antinuclear antibodies in non‐alcoholic steatohepatitis
  Hepatology Research, 2007
• Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
  Diabetes, 2007
• Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?
  Journal of Gastroenterology, 2005
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
  Hepatology, 2005
• Biopersistence of Synthetic Vitreous Fibers and Amosite Asbestos in the Rat Lung Following Inhalation
  Toxicology and Applied Pharmacology, 1998